Related Experiment Video

Updated: Aug 24, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Selective inhibition of bleomycin-induced G2 cell cycle checkpoint by simaomicin alpha

Masayoshi Arai1, Hitoshi Sato, Hidetaka Kobayashi

  • 1Kitasato Institute for Life Sciences and Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, Tokyo 108-8641, Japan.

Biochemical and Biophysical Research Communications
|April 15, 2004
PubMed

Insights

Simaomicin alpha selectively disrupts the G2 cell cycle checkpoint in cancer cells, sensitizing them to chemotherapy. This compound abrogates bleomycin-induced G2 arrest in Jurkat cells without affecting normal cells.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Pharmacology

Background:

  • Jurkat cells, derived from human T-cell leukemia, exhibit a G1 checkpoint defect.
  • Bleomycin induces G2 phase cell cycle arrest in Jurkat cells, while colchicine causes M phase arrest.

Purpose of the Study:

  • To investigate the effect of simaomicin alpha on the cell cycle regulation of cancer cells.
  • To determine if simaomicin alpha can selectively target cancer cell checkpoints.

Main Methods:

  • Treatment of Jurkat cells and HUVEC cells with simaomicin alpha, bleomycin, and colchicine.
  • Analysis of cell cycle status using flow cytometry.

Main Results:

  • Simaomicin alpha (0.6-6.0 nM) abrogated bleomycin-induced G2 arrest in Jurkat cells, increasing subG1 and G1 populations.
  • Simaomicin alpha did not affect colchicine-induced M phase arrest in Jurkat cells.
  • The compound showed minimal impact on the cell cycle of normal HUVEC cells.

Conclusions:

  • Simaomicin alpha selectively disrupts the G2 checkpoint in cancer cells.
  • This disruption sensitizes cancer cells to anti-cancer agents, suggesting therapeutic potential.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...